Inventor · disambiguated record
Peter Nussbaumer
Also filed as: NUSSBAUMER PETER
18 granted patents·8 pending applications·59 citations·filing 1987–2022
91Inventor score
Top patents by PatentIndex Score
26 records- 0179US9096608B2Pharmaceutically active pyrazolo-triazine derivativesLEAD DISCOVERY CENTER GMBH·Filed 2013·Granted Aug 4, 2015·6 cites·5 claims
- 0274US9242937B2Pharmaceutically active disubstituted pyridine derivativesRÜHTER GERD·Filed 2012·Granted Jan 26, 2016·5 cites·7 claims
- 0374US7169817B2Bis-aromatic alkanolsIRM LLC·Filed 2003·Granted Jan 30, 2007·12 cites·7 claims
- 0473US9226929B2Pharmaceutically active disubstituted triazine derivativesRÜHTER GERD·Filed 2012·Granted Jan 5, 2016·4 cites·8 claims
- 0570US6346626B1Chromanone and thiochromanone compoundsNOVARTIS AG·Filed 2000·Granted Feb 12, 2002·8 cites·9 claims
- 0668US9453051B2Cyclosporin derivativesFISCHER GUNTER·Filed 2012·Granted Sep 27, 2016·3 cites·8 claims
- 0762US4939148AAmine derivatives, processes for their production and their useSANDOZ LTD·Filed 1987·Granted Jul 3, 1990·5 cites·9 claims
- 0860US7825260B2Aminopropanol derivatives as sphingosine-1-phosphate receptor modulatorsNOVARTIS AG·Filed 2004·Granted Nov 2, 2010·1 cites·10 claims
- 0958US2024294522A13-substituted 1h-pyrrolo[2,3-b]pyridine as grk5 modulatorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 1055US5990116ATrisubstituted phenyl derivativesNOVARTIS AG·Filed 1996·Granted Nov 23, 1999·13 cites·11 claims
- 1154US2024415819A1Macrocyclic compounds as proteasome subunit beta type-5 inhibitorsLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 1252US2024252454A1Composition comprising an inhibitor of mitochondrial transcriptionLEAD DISCOVERY CENTER GMBH·Filed 2022·Application pending·0 cites
- 1348US7928093B2Amino-propanol derivativesNOVARTIS AG·Filed 2005·Granted Apr 19, 2011·0 cites·4 claims
- 1447US12281079B2Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancerLEAD DISCOVERY CENTER GMBH·Filed 2020·Granted Apr 22, 2025·0 cites·20 claims
- 1547US2008139551A1Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseasesAVANIR PHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 1645US11111238B2Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancerLEAD DISCOVERY CENTER GMBH·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 1744US10703735B24-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancerLEAD DISCOVERY CENTER GMBH·Filed 2019·Granted Jul 7, 2020·0 cites·14 claims
- 1844US2022370440A14-substituted pyrrolo[2,3-b]pyridine as erbb modulators useful for treating cancerLEAD DISCOVERY CENTER GMBH·Filed 2019·Application pending·0 cites
- 1943US7122184B2Specific monoclonal antibody against terbinafineNOVARTIS AG·Filed 2001·Granted Oct 17, 2006·0 cites·4 claims
- 2042US2008262254A1SphingolipidsETTMAYER PETER·Filed 2006·Application pending·0 cites
- 2140US2008318255A1Fluorescent Labeled SphingosinesBILLICH ANDREAS·Filed 2004·Application pending·0 cites
- 2236US5488135ABis(phenyl)ethane derivativesSANDOZ LTD·Filed 1992·Granted Jan 30, 1996·2 cites·8 claims
- 2336US2013079345A1Pharmaceutically active disubstituted triazine derivativesEICKHOFF JAN·Filed 2011·Application pending·0 cites
- 2432US12060362B2Inhibitors of glucose transporters (GLUTs)LEAD DISCOVERY CENTER GMBH·Filed 2019·Granted Aug 13, 2024·0 cites·9 claims
- 2532US7482462B2Acylsulfonamides as inhibitors of steroid sulfataseHORVATH AMARYLLA·Filed 2002·Granted Jan 27, 2009·0 cites·4 claims
- 2631US5112851AAmine derivatives, processes for their production and their useSANDOZ LTD·Filed 1990·Granted May 12, 1992·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →